首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Clinical hematology international

缩写:

ISSN:2590-0048

e-ISSN:

IF/分区:0.0/

文章目录 更多期刊信息

共收录本刊相关文章索引221
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Kian J Rahbari,Parth C Patel,Sarah Profitt et al. Kian J Rahbari et al.
Acute promyelocytic leukemia (APL) is frequently curable in the modern era using the chemotherapy-free regimen of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO). However, rare disease manifestations and treatment complications ma...
M Christina Cox,Claudia Seimonte,Erica Giacobbi et al. M Christina Cox et al.
Angioimmunoblastic T-cell lymphoma (AITL) is a rare and aggressive peripheral T-cell lymphoma of T-follicular helper (TFH) cell origin, characterized by systemic manifestations, immune dysregulation, and frequent secondary B-cell proliferat...
Jaleel A Mohammed,Caroline Couthard,Ahmed AlGhamdi et al. Jaleel A Mohammed et al.
Background: Chronic graft versus host disease (cGVHD) is a complex post-transplant complication resulting in varying degrees of musculoskeletal (MSK) manifestations, including sclerosis-type skin conditions, fasciitis, an...
Manan Nath,Anshul Vagrecha,Annie H Roliz et al. Manan Nath et al.
Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening hyperimmune condition triggered by the pathological activation of T-cells, natural killer cells, and macrophages leading to a cytokine storm with widespread hyperinflammation af...
Jeremy W Jacobs,Garrett S Booth,Victoria Costa et al. Jeremy W Jacobs et al.
Factor XIII (FXIII) deficiency is a rare bleeding disorder characterized by unstable hemostatic clots due to defective fibrin cross‑linking. Congenital FXIII deficiency arises from variants in the F13A1 (FXIII-A subunit) or F13B (FXIII-B s...
Vincent Luong,Muhammad Kashif,Katarina Uttervall et al. Vincent Luong et al.
The use of proteasome inhibitors (PI) and immunomodulatory drugs (IMiD) such as lenalidomide (Len) in early lines of therapy in multiple myeloma (MM) has resulted in a high proportion of patients with relapsed or refractory multiple myeloma...